Ebel Florian, Greuter Ladina, Licci Maria, Guzman Raphael, Soleman Jehuda
Department of Neurosurgery, University Hospital of Basel, 4031 Basel, Switzerland.
Division of Pediatric Neurosurgery, University Children's Hospital of Basel, 4056 Basel, Switzerland.
J Clin Med. 2021 Aug 29;10(17):3889. doi: 10.3390/jcm10173889.
The development of minimally invasive neuroendoscopy has advanced in recent years. The introduction of the neuroendoscopic ultrasonic aspirator (NUA) broadened the treatment spectrum of neuroendoscopy. We aim to describe our experience with the use of NUA for the resection of intraventricular lesions. Here, we present consecutive retrospective case series of adult and pediatric patients undergoing resection of an intraventricular lesion with a NUA (Endoscopic Neurosurgical Pen, Söring GmbH, Quickborn, Germany) between January 2019 and April 2020. Eight patients between the age of 0.5 and 73 years underwent surgery using NUA and were included in this study. In four patients, an endoscopic assisted (EA) resection of the lesion was undertaken, while in four patients, the lesion was removed using purely endoscopic (PE) resection. In all cases, gross/near total resection was achieved. The average blood loss was 142.5 ± 90.4 mL (range 50-300 mL). Transient morbidity was seen in four patients (50%), while permanent morbidity or mortality did not occur. The NUA seems to be a safe and valuable tool for the minimally invasive resection of intraventricular lesions in selected cases. The type, size, consistency, and vascularization of the lesion limit at times the purely endoscopic use of the NUA.
近年来，微创神经内镜技术有了进一步发展。神经内镜超声吸引器（NUA）的引入拓宽了神经内镜的治疗范围。我们旨在描述使用NUA切除脑室内病变的经验。在此，我们呈现了2019年1月至2020年4月期间，使用NUA（德国奎克伯恩市索林有限公司生产的内镜神经外科笔）切除脑室内病变的成年和儿科患者的连续回顾性病例系列。8例年龄在0.5岁至73岁之间的患者接受了使用NUA的手术，并纳入本研究。4例患者采用内镜辅助（EA）切除病变，4例患者采用单纯内镜（PE）切除病变。所有病例均实现了大体/近全切除。平均失血量为142.5±90.4毫升（范围50 - 300毫升）。4例患者（50%）出现短暂性并发症，未发生永久性并发症或死亡。在特定病例中，NUA似乎是一种用于微创切除脑室内病变的安全且有价值的工具。病变的类型、大小、质地和血管化情况有时会限制NUA的单纯内镜使用。
